tetrahydropapaverine has been researched along with Arthritis, Rheumatoid in 1 studies
tetrahydropapaverine: RN given refers to parent cpd
1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline : A benzylisoquinoline alkaloid that is norlaudanosoline in which the four phenolic hydrogens have been replaced by methyl groups.
Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Park, YH | 1 |
| Kim, HJ | 1 |
| Lee, K | 1 |
| Choi, Y | 1 |
| Heo, TH | 1 |
1 other study available for tetrahydropapaverine and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Combination of gp130-targeting and TNF-targeting small molecules in alleviating arthritis through the down-regulation of Th17 differentiation and osteoclastogenesis.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Cell Differentiation; Cell Line; Cytokine R | 2020 |